Noticias de UTHR_US
Noticias del mercado
Últimas noticias sobre UTHR_US — 303 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Ticker: UTHR_US ✕
303 resultados
Up to 800,000 people have high blood pressure in the lungs linked to chronic lung disease. An inhaler trial can proceed.
The phase 2 study will assess treprostinil SMI’s safety and tolerability in about 40 patients over 16 weeks; phase 3 is anticipated in 2028 if SUMMIT succeeds.
After exercising options at $117.76 each, CEO trust sells 9,500 United Therapeutics (UTHR) shares.
The family trust retained 223,910 options expiring March 15, 2027. Its October 15 exercise and sales followed a trading plan adopted November 7, 2025.
An 8,300-share planned sale follows an option exercise by United Therapeutics (UTHR) counsel.
Six sales on October 15, 2026, had weighted-average prices of $541.6421 to $546.5608. Paul A. Mahon held 30,940 options after the exercise.
Página 2 de 16